"Southwest Florida Research (SWFR) is a research center of excellence for the administration of Phase II-IV clinical trials in pharmaceutical and medical devices. We also operate as a healthcare business incubator and market research firm dedicated to researching and sponsoring innovation in healthcare delivery."

During the past decade, Southwest Florida Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Florida Research" #1 sponsor was "Bayer" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Brigham and Women's Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Florida Research" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Florida Research" are "Cardiovascular Disease" (4 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "ASCVD" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Southwest Florida Research" in a lesser frequency.

Most popular intervention types in "Southwest Florida Research" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Florida Research" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Florida Research". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Southwest Florida Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Florida Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".